What's breaking now, across thousands of outlets.
(RTTNews) - Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration (FDA) approved TUKYSA in combination with trastuzumab and pertuzumab for maintenance treatment of adults with unresectable, locally advanced, or metastatic human epidermal growth factor 2-positive
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
New Nemluvio® (nemolizumab) post-hoc data from the ARCADIA long-term extension (LTE) study showed the majority of Week 16 responders maintained deep and lasting skin lesion and itch response for up to…
Investigators are tracing the journey of Kenyas first confirmed Ebola patient from treatment in eastern DRC through Uganda to Nairobi, raising questions about how he crossed borders while ill.
After more than a decade of symptoms, Dr Rachel O'Connor says she was told her endometriosis was "too severe" to treat in Ireland
The shortage of Lenzetto has had a domino effect on other menopause hormone treatments in Spain and other European countries.
The World Health Organisation (WHO) has advised Kenya against closing its borders following the country’s first confirmed Ebola case, saying blanket travel and trade restrictions would do little to…
